Veterinary Point-Of-Care (POC) Hematology Diagnostics Market Report 2026

Veterinary Point-Of-Care (POC) Hematology Diagnostics Market Overview

• Veterinary Point-Of-Care (POC) Hematology Diagnostics market size has reached to $1.6 billion in 2025 • Expected to grow to $2.93 billion in 2030 at a compound annual growth rate (CAGR) of 12.9% • Growth Driver: Rising Pet Ownership Driving Market Growth Due To Rising Demand For Rapid And Accurate Health Diagnostics • Market Trend: Innovative Hematology Analyzers Driving Advances In Veterinary Point-Of-Care Diagnostics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Veterinary Point-Of-Care (POC) Hematology Diagnostics Market?

Veterinary point-of-care (POC) hematology diagnostics refers to rapid, on-site diagnostic testing technologies used by veterinarians to evaluate various blood parameters in animals, including red blood cell count, white blood cell count, hemoglobin concentration, hematocrit levels, and platelet count, directly at the location of care such as clinics, farms, or animal shelters. These diagnostics enable timely decision-making, faster treatment planning, and improved patient outcomes by eliminating delays in sending samples to external laboratories. The main product types of veterinary point-of-care (POC) hematology diagnostics are instruments and consumables. Instruments used in veterinary clinics are specialized machines that quickly and accurately analyze animal blood samples to support timely diagnosis and treatment. These diagnostics are used for various animal types, including livestock animals, companion animals, and other animal types. Applications include blood disorders, metabolic disorders, and other conditions. The key end-users include veterinary clinics, veterinary hospitals, research laboratories, and other end-users.

What Is The Veterinary Point-Of-Care (POC) Hematology Diagnostics Market Growth Forecast?

The veterinary point-of-care (poc) hematology diagnostics market size is expected to see rapid growth in the next few years. It will grow to $2.93 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to innovations in portable hematology analyzers, rising demand for rapid and accurate diagnostics, expansion of veterinary point-of-care services, integration of digital reporting and cloud-based data management, growing investments in livestock and companion animal health monitoring. Major trends in the forecast period include growing adoption of point-of-care hematology diagnostics in veterinary clinics, rising demand for rapid blood analysis tools for companion animals, increasing use of consumables such as reagents and calibrators for on-site testing, expansion of veterinary research laboratories offering on-site hematology testing, development of portable and user-friendly analyzer instruments.

Global Veterinary Point-Of-Care (POC) Hematology Diagnostics Market Segmentation

1) By Product Type: Instruments, Consumables 2) By Animal Type: Livestock Animals, Companion Animals, Other Animal Types 3) By Application: Blood Disorders, Metabolic Disorders, Other Applications 4) By End User: Veterinary Clinics, Veterinary Hospitals, Research Laboratories, Other End-Users Subsegments: 1) By Instruments: Analyzers, Blood Gas Electrolyte Analyzers, Coagulation Analyzers 2) By Consumables: Reagents, Controls And Calibrators, Slides, Cuvettes

What Is The Driver Of The Veterinary Point-Of-Care (POC) Hematology Diagnostics Market?

The increasing pet ownership is expected to propel the growth of the veterinary point-of-care (POC) hematology diagnostics market going forward. Pet ownership refers to caring for a domesticated animal, such as a dog, cat, bird, or other pet, by providing for its basic needs, well-being, and overall welfare. The increasing pet ownership is primarily attributed to rising urbanization, as more people in cities seek companionship and emotional support from pets in smaller, often isolated living spaces. Veterinary point-of-care (POC) hematology diagnostics supports pet ownership by enabling rapid, on-site blood analysis that leads to quicker diagnoses, timely treatments, and improved health outcomes for companion animals. For instance, in 2024, according to the report published by Shelter Animals Count, a US-based non-profit organization, in 2024, total dog and cat adoptions reached 4,192,443, including 2 million dogs and 2 million cats, reflecting a slight increase of 0.4% or 17,153 more adoptions compared to 2023. Therefore, the increasing pet ownership is driving the growth of the veterinary point-of-care (POC) hematology diagnostics industry.

Key Players In The Global Veterinary Point-Of-Care (POC) Hematology Diagnostics Market

Major companies operating in the veterinary point-of-care (poc) hematology diagnostics market are Zoetis Inc., IDEXX Laboratories, Sysmex Corp., HORIBA Medical, Virbac, Randox Laboratories Ltd., Heska Corporation, Getein Animal Medical Technology, Boule Diagnostics AB, Genrui Biotech Inc., Eurolyser Diagnostica GmbH, Bioevopeak, Mindray Bio‑Medical Electronics Co. Ltd., HemoCue AB, EKF Diagnostics Holdings PLC, Scil Animal Care Company GmbH, Diatron MI Zrt, Clindiag Systems Co. Ltd., Drew Scientific Inc., URIT Medical Electronics Co. Ltd., ERBA Diagnostics Inc., Balio Diagnostics, Shenzhen Dymind Biotechnology Co. Ltd., Analytical Technologies Limited, Seamaty Technology Co. Ltd.

Global Veterinary Point-Of-Care (POC) Hematology Diagnostics Market Trends and Insights

Major companies operating in the veterinary point-of-care (POC) hematology diagnostics market are focusing on developing innovative products, such as veterinary analyzers, to improve diagnostic accuracy and speed in clinical settings. Veterinary analyzers are medical diagnostic devices used in animal healthcare to evaluate biological samples such as blood, urine, or serum. These devices help veterinarians diagnose, monitor, and manage various animal health conditions by providing rapid and accurate test results. For instance, in August 2023, Seamaty Diagnostic Co., Ltd., a China-based medical equipment manufacturing company, launched four advanced veterinary analyzers designed to provide fast and accurate on-site diagnostics, significantly improving pet hospitals' efficiency and quality of care. These analyzers include the VG2 vet blood gas electrolyte immunoassay analyzer, which offers rapid combined blood gas and immunoassay testing; the VG1 veterinary blood gas & electrolyte analyzer, a portable device for critical care monitoring; the Vi1 veterinary fluorescence immunoassay analyzer, featuring cutting-edge nanocrystal technology for sensitive diagnostics, and the VBC30/VBC50 hematology analyzers, which perform detailed blood counts essential for early disease detection.

What Are Latest Mergers And Acquisitions In The Veterinary Point-Of-Care (POC) Hematology Diagnostics Market?

In June 2023, Mars Inc., a US-based pet care company, acquired Heska Corp. for $1.3 billion. With this acquisition, Mars aims to strengthen its position in the animal diagnostics market by integrating Heska’s advanced veterinary diagnostic technologies into its science and diagnostics division, addressing the growing demand fueled by increased pet ownership. Heska Corp. is a US-based veterinary services company that manufactures advanced veterinary diagnostics, including point-of-care (POC) hematology diagnostics.

Regional Outlook

North America was the largest region in the veterinary point-of-care (POC) hematology diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Veterinary Point-Of-Care (POC) Hematology Diagnostics Market?

The veterinary point-of-care (POC) hematology diagnostics market includes revenues earned by providing services such as remote monitoring and connectivity, data analysis and reporting, quality control and proficiency testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary point-of-care (POC) hematology diagnostics market also consists of sales of portable handheld analyzers, compact benchtop analyzers, and microfluidic cartridge-based modules. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.